Our growing Membership is drawn from all facets of the Life Sciences including academia, companies and organisations active in both therapeutics discovery and development and medical technology. We also have a large number of Members in the associated industries, such as legal, regulatory and finance.
Collectively, they present a resource, both for each other and as consultants for sector development. As an example, OBN Members have contributed to a University of Oxford initiative examining the University’s aspirations, activities and future strategy in relation to knowledge exchange and its contribution to the innovation eco-system.
Sector representation in local development
OBN has close contacts with key movers within the Oxford and Thames Valley life sciences ecosystem including Oxford LEP, Oxford AHSN and AHSC, Oxford University Medical Sciences Division, Oxford Brookes University, Structural Genomics Consortium (SGC), Oxford University Hospitals (OUH) NHS Trust, Invest in Oxford, Oxford City Council, Science Park owners and operators and others.
We have contributed to initiatives such as the BioEscalator, Milton Science Centre, Harwell Open Innovation Hub and the Didcot UTC and are active on issues concerning property and labspace provision and in attracting companies to the area.
A voice for emerging R&D companies
OBN has grown in influence since its foundation in 1997 and Membership has grown to include organisations in and around Oxford, Cambridge, London, Nottingham, Manchester and in Scotland. OBN lays claim to being the membership organisation supporting the interests of the UK’s innovative life sciences R&D companies.
Increasingly, OBN is asked to contribute to regional and national-level initiatives and consultations relating to sector growth. For further information about OBN’s Advocacy activities, contact John Harris.